Table 1 Clinical features of pediatric patients included in this study
No | Sex | Age (years) | CKD stage | Left kidney | Righ kidney | Primary diagnosis | ||||
|---|---|---|---|---|---|---|---|---|---|---|
LD | SD | RI | LD | SD | RI | |||||
1 | Male | 6.5 | CKD 0 | 8.4 | 4.2 | 0.62 | 8.3 | 4.2 | 0.62 | None |
2 | Male | 10.3 | CKD 0 | 9.1 | 4 | 0.64 | 9 | 4 | 0.67 | None |
3 | Female | 2.4 | CKD 0 | 7.4 | 3.2 | 0.68 | 7.4 | 3.4 | 0.69 | None |
4 | Female | 6.7 | CKD 1 | 7.8 | 3.6 | 0.67 | 7.8 | 3.7 | 0.65 | Nephrotic syndrome |
5 | Female | 11.7 | CKD 1 | 10.2 | 3.9 | 0.68 | 9.7 | 3.7 | 0.66 | Nephrotic syndrome |
6 | Male | 8.7 | CKD 1 | 8.8 | 4.3 | 0.59 | 8.9 | 4.4 | 0.63 | Nephrotic syndrome |
7 | Male | 1.6 | CKD 1 | 5.7 | 2.7 | 0.85 | 6.1 | 3 | 0.89 | Hypercalciuria |
8 | Male | 10.7 | CKD 1 | 9.3 | 4.6 | 0.63 | 9.8 | 4 | 0.62 | Alport syndrome |
9 | Female | 9.1 | CKD 1 | 8.4 | 4.1 | 0.61 | 8.2 | 4.2 | 0.61 | IgA nephropathy |
10 | Female | 8.5 | CKD 1 | 9.2 | 4 | 0.6 | 9.9 | 4.4 | 0.6 | HSPN |
11 | Female | 9.3 | CKD 1 | 8.5 | 3.8 | 0.62 | 8.3 | 4.2 | 0.56 | HSPN |
12 | Male | 6.5 | CKD 1 | 8.4 | 3.9 | 0.73 | 8.5 | 3.8 | 0.74 | IgM nephropathy |
13 | Female | 10.4 | CKD 1 | 9.4 | 4.1 | 0.66 | 9.6 | 3.9 | 0.66 | IgA nephropathy |
14 | Male | 10.2 | CKD 1 | 9.5 | 4.4 | 0.6 | 9.1 | 4.9 | 0.56 | IgA nephropathy |
15 | Female | 11.1 | CKD 1 | 9.8 | 4.1 | 0.65 | 10.4 | 4.2 | 0.68 | IgA nephropathy |
16 | Male | 10.7 | CKD 2 | 9.2 | 4.2 | 0.67 | 9.8 | 4.5 | 0.63 | IgA nephropathy |
17 | Male | 13.2 | CKD 2 | 10.8 | 4.6 | 0.63 | 10.5 | 4.5 | 0.6 | Lupus nephritis |
18 | Male | 11.3 | CKD 2 | 9.9 | 4.9 | 0.76 | 9.8 | 4.8 | 0.69 | IgA nephropathy |
19 | Female | 1.3 | CKD 2 | 7.7 | 3.3 | 0.67 | 7.6 | 3.2 | 0.66 | MPGN |
20 | Male | 7 | CKD 3 | 7.3 | 2.2 | 0.72 | 8 | 2.5 | 0.71 | Chronic interstitial nephritis |
21 | Male | 10.9 | CKD 3 | 7.6 | 3.5 | 0.61 | 8 | 3.3 | 0.58 | Primary hyperoxaluria type 1 |
22 | Male | 5.7 | CKD 5 | 7 | 2.8 | 0.63 | 6.7 | 2.4 | 0.64 | Urinary system infection |